What does MRI compatible IV infusion pumps — total revenue mean?

This metric represents the total gross revenue generated from the sale and service of MRI-compatible IV infusion pump systems. It serves as a primary indicator of market adoption and demand for the company's specialized medical device technology within magnetic resonance imaging environments. Tracking this figure allows stakeholders to assess the growth trajectory and competitive positioning of the company's core product line.

iRadimed IRMD MRI Compatible IV Infusion Pumps — Total Revenue

Other product segments

MRI Compatible Patient Vital Signs Monitoring Systems

$7.11M+8.6%

Disposables

$4.89M—

Services and other

$1.04M—

Amortization of extended maintenance agreements

$659K—

Ferro Magnetic Detection Systems

$621K+48.6%

Similar metrics at other companies

ICUIInfusion Systems — Revenue

$179.6M+8.0%

ICUIInfusion Consumables — Revenue

$278.28M+4.5%

GEHCImaging — Total revenues

$2.3B+7.4%

BAXInfusion Therapies & Technologies — Net Sales

$981M-1.3%

BFLYHardware — Total Revenue

$14.65M+3.5%

ICUIInfusion Systems — Percentage of revenue

7.8%+1.0pp

Other financials

Income statement

See full

Revenue$22.0M+12.6%

Gross profit$16.8M+13.3%

Operating income$7.2M+33.2%

Net income$5.8M+24.1%

EPS (diluted)$0.45+21.6%

Balance sheet

See full

Cash & equivalents$56.4M+12.0%

Total debt$59.2K-96.9%

Total equity$98.5M+9.4%

Total assets$114.4M+12.4%

Cash flow

See full

Operating cash flow$8.3M+93.2%

CapEx$403.0K-89.1%

Free cash flow$7.9M+1,226%

Valuation

See full

Market cap$1.21B+63.4%

P/E51.3×+13.8×

P/S14×+4.2×

Profitability

See full

Gross margin76.8%-0.1pp

Operating margin32.4%+2.3pp

Net margin27.4%+1.0pp

FCF margin28.4%+8.9pp

Returns & leverage

See full

Return on equity25%+1.2pp

Debt / equity0×0.0×

Current ratio7.1×-1.7×

Where this comes from

Reported directly by iRadimed in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's mri compatible iv infusion pumps — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is iRadimed's MRI compatible IV infusion pumps — total revenue?: iRadimed (IRMD) reported MRI compatible IV infusion pumps — total revenue of $7.66M in Q1 2026.
What does MRI compatible IV infusion pumps — total revenue mean?: This metric represents the total gross revenue generated from the sale and service of MRI-compatible IV infusion pump systems. It serves as a primary indicator of market adoption and demand for the company's specialized medical device technology within magnetic resonance imaging environments. Tracking this figure allows stakeholders to assess the growth trajectory and competitive positioning of the company's core product line.